|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Monogram Biosciences, Inc.
| | | Phone: | (650) 635-1100 | Year Established: | 1995 | Ticker: | LH | Exchange: | NYSE | Main Contact: | William J. Welch, Senior VP & CCO | | Other Contacts: | Jeannette M. Whitcomb, Ph.D., VP, Operations Michael G. Vicari,, VP, Sales Christos J. Petropoulos, Ph.D., VP, Research and Development, Virology & CSO Alfred G. Merriweather,, Senior VP & CFO Gordon Parry, Ph.D., VP, Research and Development, Oncology Kenneth N. Hitchner, VP, Pharmaceutical Collaborations Kathy L. Hibbs, Senior VP, General Counsel Timothy G. Henn,, VP, Finance Michael P. Bates, MD, VP, Clinical Research William D. Young, Chairman & CEO
| | Company Description | Monogram (formerly ViroLogic) is a leader in developing and commercializing innovative diagnostic products to help guide and improve the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. Monogram’s services enable health care providers to optimize treatment regimens for their patients. They also support pharmaceutical companies in developing new and improved antiviral therapeutics and vaccines and targeted cancer therapeutics.
Monogram Biosciences is a member of the LabCorp Specialty Testing Group. Monogram is a leading commercial company that performs HIV phenotypic testing. Monogram provides testing for clinical patient management and drug/vaccine development, and supports clinical trials directly and as part of the Covance Drug Development team. | |
|
|
|
|
|